Blood Cancer Talks
Episodes
Episode 70. ASH 2025 Myeloid Neoplasm Roundup with Dr. Curtis Lachowiez
27 Feb 2026
Contributed by Lukas
In this episode, we dive deep into ASH 2025 updates on myeloid malignancies with Dr. Curtis Lachowiez. From the plenary halls of ASH 2025 to long-term...
Episode 69. ASH 2025 Lymphoma Roundup with Dr. Carla Casulo
22 Jan 2026
Contributed by Lukas
BloodCancerTalks: ASH 2025 Lymphoma RoundupGuest: Dr. Carla Casulo, Associate Professor, Wilmot Cancer Centre, University of RochesterAbstracts Discus...
Episode 68. ASH 2025 Myeloma Special: MajesTEC-3 and the Bispecific Revolution with Dr. Luciano Costa
02 Jan 2026
Contributed by Lukas
 Join hosts Raj, Ashwin, and Eddie in this episode of Blood Cancer Talks as they welcome Dr. Luciano Costa, the first author of the NEJM manuscript o...
Episode 67. Management of CMV in Hematologic Malignancies
23 Nov 2025
Contributed by Lukas
Join hosts Eddie, Ashwin, and Raj as they welcome Dr. Michelle Yong and Dr. Gemma Reynolds, academic infectious diseases physicians from the Peter Mac...
Episode 66. International Myeloma Society 2025 Annual Meeting Updates with Dr. Alfred Garfall: The Bispecific Bonanza
15 Oct 2025
Contributed by Lukas
This episode provides comprehensive coverage of key clinical trial updates from the 2025 International Myeloma Society (IMS) Annual Meeting in Toronto...
Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain
24 Sep 2025
Contributed by Lukas
In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating...
Episode 64. Lymphoma Updates from EHA and ICML 2025 with Dr. Adrian Minson
20 Aug 2025
Contributed by Lukas
In this episode of Blood Cancer Talks, we have Dr. Adrian Minson from the Peter MacCallum Cancer Centre to discuss the latest developments in lymphoma...
Episode 63. Management of Follicular Lymphoma with Dr. Gilles Salles
25 Jul 2025
Contributed by Lukas
In this episode, we discuss the management of follicular lymphoma with Dr. Gilles Salles from Memorial Sloan Kettering Cancer Center. Here are the art...
Episode 62. Unpacking MIDAS Trial in Myeloma with Dr. Meera Mohan
09 Jul 2025
Contributed by Lukas
In this episode, we dissect the phase 3 MIDAS trial in newly diagnosed transplant-eligible multiple myeloma with Dr. Meera Mohan. https://pubmed.ncbi...
Episode 61. Menin Inhibitors in AML with Dr. Eytan Stein
24 Jun 2025
Contributed by Lukas
In this episode, we took a deep dive intro the landscape of menin inhibitors in AML with Dr. Eytan Stein from MSKCC. Here are the key trials and studi...
Episode 60. Emergency Podcast-AQUILA and STARGLO
28 May 2025
Contributed by Lukas
In this episode, we discuss the recent proceedings at the FDA ODAC meeting on AQUILA trial in smoldering myeloma and STRAGLO in R/R DLBCL, and provide...
Episode 59. Management of Systemic Mastocytosis with Dr. Daniel DeAngelo
08 May 2025
Contributed by Lukas
In this episode, we discussed the management of systemic mastocytosis with Dr. Daniel DeAngelo from the Dana Farber Cancer Institute. Here are the key...
Episode 58: CAR Transgenic T-cell Lymphoproliferative Neoplasms (CTTLN) with Dr. Piers Blombery
26 Mar 2025
Contributed by Lukas
In this episode, we explore the emerging entity of CAR Transgenic T-cell Lymphoproliferative Neoplasms (CTTLN), a rare but important complication of C...
Episode 57. ASH 2024 Update on Leukemia/Myeloid Neoplasms with Dr. Jayastu Senapati
19 Mar 2025
Contributed by Lukas
In this episode, we delve into the key clinically relevant abstracts in leukemia and myeloid neoplasms with Dr. Jayastu Senapati from the MD Anderson ...
Episode 56. Management of Newly Diagnosed CML with Dr. Hagop Kantarjian
12 Feb 2025
Contributed by Lukas
In this episode, we discuss the management of CML with Dr. Hagop Kantarjian from MD Anderson Cancer Center. Here are the key articles we discussed:Â Â ...
Episode 55. ASH 2024 Myeloma Updates with Dr. Rakesh Popat
11 Jan 2025
Contributed by Lukas
In this episode, we dive into the hottest updates in myeloma and amyloidosis at ASH 2024 annual meeting with Dr. Rakesh Popat. Here are the abstracts ...
Episode 54. ASH 2024 Lymphoma and CLL Highlights with Dr. David Russler-Germain
22 Dec 2024
Contributed by Lukas
In this episode, we discussed the top abstracts in lymphoma and CLL presented at the ASH 2024 annual meeting in San Diego with Dr. David A Russler-Ger...
Episode 53. Belantamab Makes a Comeback with Dr. Hang Quach
13 Nov 2024
Contributed by Lukas
In this episode, we discuss the comeback of belantamab mafadotin in multiple myeloma with Dr. Hang Quach, along with some other important abstracts pr...
Episode 52. Management of Hodgkin Lymphoma in Older Adults with Dr. Andrew Evens
26 Oct 2024
Contributed by Lukas
In this episode, we dive into the management of older adults with Hodgkin Lymphoma with Dr. Andrew Evens. Here are the key articles we discussed: 1. C...
Episode 51. Venetoclax in AML with Dr. Andrew Wei
27 Sep 2024
Contributed by Lukas
In this episode, we discuss the history of venetoclax in AML, along with key clinical trials that have shaped its current use in AML. Here are the tri...
Episode 50. Quadruplets in Newly Diagnosed Transplant-Ineligible Myeloma with Dr. Timothy Schmidt
29 Aug 2024
Contributed by Lukas
In this episode, we discuss the management of newly diagnosed transplant in-eligible multiple myeloma with Dr. Timothy Schmidt, with a special focus o...
Episode 49. Updates on Low-Risk MDS with Dr. Maximilian Stahl
14 Aug 2024
Contributed by Lukas
In this episode, we discuss updates on low-risk MDS with Dr. Maximilian Stahl with a focus on imetelstat and luspatercept. Here are the trials we dis...
Episode 48. Management of Polycythemia Vera with Dr. Aaron Gerds
21 Jul 2024
Contributed by Lukas
In this episode, we discussed the diagnosis and management of polycythemia vera with Dr. Aaron T. Gerds. Here are the shownotes with the key studies d...
Episode 47. ASCO/EHA 2024 Lymphoma Updates with Dr. Gloria Iacoboni
06 Jul 2024
Contributed by Lukas
In this episode, we reviewed the hottest updates in lymphoma from ASCO and EHA 2024, held in Chicago and Madrid respectively, with Dr. Gloria Iacoboni...
Episode 46. Updates in Myeloma MRD with Dr. Ben Derman and Dr. Manni Mohyuddin
09 Jun 2024
Contributed by Lukas
In this episode, we dive into updates in Minimal Residual Disease (MRD) in multiple myeloma, along with the FDA ODAC meeting in April 2024 to decide o...
Episode 45. Updates in Primary Myelofibrosis with Dr. Ayalew Tefferi
29 May 2024
Contributed by Lukas
In this episode, we discuss updates in primary myelofibrosis with Dr. Ayalew Tefferi from the Mayo Clinic. The key studies and trials discussed are a...
Episode 44. Maintenance Therapy in Multiple Myeloma with Dr. Hira Mian and Dr. Manni Mohyuddin
01 May 2024
Contributed by Lukas
In this episode, we dive into the data on maintenance therapy in multiple myeloma with Dr. Hira Mian and Dr. Manni Mohyuddin. Here are the key studies...
Episode 43. Essential Thrombocythemia with Dr. Raajit Rampal
18 Apr 2024
Contributed by Lukas
In this episode, we discuss the diagnosis and management of Essential Thrombocythemia with Dr. Raajit Rampal. Here are the shownotes:1.   IPSET (...
Episode 42. CAR T-cell Therapy in Early Relapsed Myeloma with Dr. Samer Al Hadidi
27 Mar 2024
Contributed by Lukas
In this episode, we talked about overall survival data from CARTITUDE-4 and KarMMa-3 that was presented at FDA ODAC meeting with Dr. Samer Al Hadidi f...
Episode 41. Career Development as a Clinician-Investigator with Dr. Ayalew Tefferi
14 Mar 2024
Contributed by Lukas
In this episode, we discuss mentorship and career development as a clinician-investigator with Dr. Ayalew Tefferi from the Mayo Clinic.Â
Episode 40. Management of Newly Diagnosed AL Amyloidosis with Dr. Angela Dispenzieri
21 Feb 2024
Contributed by Lukas
In this episode we discuss the management of newly diagnosed AL amyloidosis with Dr. Angela Dispenzieri from the Mayo Clinic. Here are the key articl...
Episode 39. ASH 2023 Leukemia and Myeloid Neoplasm Recap with Dr. Anand Patel
08 Feb 2024
Contributed by Lukas
In this episode, we discuss top abstracts in the myeloid space from the American Society of Hematology 2023 meeting with Dr. Anand Patel. Here are th...
Episode 38. GVHD Prophylaxis in Allo-Transplant with Dr. Shernan Holtan
19 Jan 2024
Contributed by Lukas
In this episode, we talk about GVHD prophylaxis, including recent data on post-transplant cyclophosphamide and abatacept with Dr. Shernan Holtan from ...
Episode 37. ASH 2023 Myeloma Recap with Dr. Ben Derman
27 Dec 2023
Contributed by Lukas
In this episode, we discuss the key abstracts in myeloma and related plasma cell disorders at ASH23 with Dr. Benjamin Derman. Here are the abstracts d...
Episode 36. ASH 2023 Lymphoma Recap with Dr. Toby Eyre
20 Dec 2023
Contributed by Lukas
In this episode, we review the hottest updates in lymphoma from the American Society of Hematology 2023 meeting with Dr Toby Eyre, a consultant haemat...
Episode 35. Bispecific Antibodies in Lymphoma with Dr. Michael Dickinson
30 Nov 2023
Contributed by Lukas
In this episode, we delve into the weeds of bispecific antibodies across lymphomas with Dr. Michael Dickinson from Peter MacCallum Cancer Center, Melb...
Episode 34. Management of FLT3 AML with Dr. Alexander Perl
17 Nov 2023
Contributed by Lukas
In this episode, we dive into the management of newly diagnosed and relapsed FLT3-positive AML with Dr. Alexander Perl.Here are the shownotes:1. Asses...
Episode 33. The art of caring for patients at the end of life with Dr. Azra Raza
01 Nov 2023
Contributed by Lukas
In this episode, we discuss the art of caring for terminally ill patients with Dr. Azra Raza. We also discuss her book titled "The First Cell", where...
Episode 32: t(11;14) Multiple Myeloma and Role of Venetoclax with Dr. Rafael Fonseca and Dr. Martin Kaiser
18 Oct 2023
Contributed by Lukas
In this episode, we discuss the biology and management of t(11;14) multiple myeloma and the role of venetoclax with Dr. Rafael Fonseca and Dr. Martin ...
Episode 31. Management of CNS Lymphoma
04 Oct 2023
Contributed by Lukas
In this episode, we discuss the management of primary CNS lymphoma, secondary CNS lymphoma and CNS prophylaxis with Dr. Kate Cwynarski. Here are the s...
Episode 30. Management of High-Risk Myeloma
13 Sep 2023
Contributed by Lukas
In this episode, we discuss with Dr. Martin Kaiser how to identify and manage newly diagnosed high-risk multiple myeloma in the current era of effecti...
Episode 29. Management of Peripheral T-Cell Lymphoma
30 Aug 2023
Contributed by Lukas
In this episode, we discuss the diagnosis and management of peripheral T-cell lymphoma with Dr. Steven Horwitz, with a focus on the 3 most common type...
Episode 28. Management of CCUS
18 Aug 2023
Contributed by Lukas
In this episode, we discuss the diagnosis and management/monitoring of Clonal Cytopenias of Unknown Significance (CCUS) with Dr. Uma Borate. We also d...
Episode 27. Management of PNH
31 Jul 2023
Contributed by Lukas
In this episode, we delve into the diagnosis and management of Paroxysmal Nocturnal Hemoglobinuria (PNH) with Dr. Robert Brodsky. Here are the showno...
Episode 26. Management of Newly Diagnosed Hodgkin's Lymphoma
15 Jul 2023
Contributed by Lukas
In this episode, we delve into the history of frontline treatment in young/fit patients with Hodgkin's lymphoma and recent developments in the past de...
Episode 25. Managing Acute Toxicities of CAR T-cell Therapy
28 Jun 2023
Contributed by Lukas
In this episode, we discuss the management of acute toxicities of CAR T-cell therapy, including CRS, ICANS, and HLH with Dr. Michael Jain from Moffitt...
Episode 24. ASCO/EHA 2023 Special: Updates on CAR T-cell Therapy in Myeloma
17 Jun 2023
Contributed by Lukas
In this episode, we discuss the latest updates on CAR T-cell therapy in multiple myeloma, including the studies presented at ASCO and EHA 2023. Here a...
Episode 23. Bispecific Antibodies in Myeloma
31 May 2023
Contributed by Lukas
In this episode, we delve into the latest data on bispecific antibodies in multiple myeloma with Dr. Ajai Chari. Here are the key studies discussed:1....
Episode 22. Management of Low-Risk MDS
20 May 2023
Contributed by Lukas
In this episode, we take a deep dive into low-risk MDS management. We have the privilege of being joined by the esteemed Dr. Mikkael Sekeres. We also ...
Episode 21. Newly Diagnosed Mantle Cell Lymphoma
03 May 2023
Contributed by Lukas
In this episode, we delve into the management of newly diagnosed mantle cell lymphoma with Dr. Martin Dreyling. Here the shownotes:2:11 How to diagnos...
Episode 20. Management of Myeloma in LMICs
19 Apr 2023
Contributed by Lukas
In this episode, we discuss the management of multiple myeloma in LMICs with Dr. Andrés Gómez-De León from UANL, Monterrey, Mexico, and Dr. Aditya ...
Episode 19. Management of Primary Myelofibrosis
06 Apr 2023
Contributed by Lukas
In this episode, we discuss the diagnosis and management of primary myelofibrosis with Dr. Ayalew Tefferi at Mayo Clinic, Rochester, Minnesota. Here a...
Episode 18. Management of Smoldering Multiple Myeloma
22 Mar 2023
Contributed by Lukas
1. How I Approach Smoldering Myeloma (Vaxman and Gertz):https://ashpublications.org/blood/article/140/8/828/485274Â 2. Risk-Stratification Models in S...
Episode 17. Acquired Aplastic Anemia
08 Mar 2023
Contributed by Lukas
In this episode, we discuss the management of acquired aplastic anemia with Dr. Amy DeZern. Here are the links to some of the key articles discussed i...
Episode 16. ASH 2022 Leukemia and Myeloid Malignancies Recap
25 Feb 2023
Contributed by Lukas
1.   Phase III ASAP trialhttps://ash.confex.com/ash/2022/webprogram/Paper159962.html  2.   Phase III Dauno-Double Trialhttps://ash.confex....
Episode 15. Management of Newly Diagnosed DLBCL (Including Bonus ASH22 Updates)
08 Feb 2023
Contributed by Lukas
In this episode, we discuss the management of newly diagnosed DLBCL with Dr. Pallawi Torka. We also have a few bonus ASH22 updates on DLBCL. Links to ...
Episode 14. MRD in Multiple Myeloma
25 Jan 2023
Contributed by Lukas
1.   Excellent paper on harmonization of performing and reporting MRD in multiple myeloma:      https://www.nature.com/articles/s41375-...
Episode 13. Management of Newly Diagnosed Younger Adults with AML
11 Jan 2023
Contributed by Lukas
Study showing the time from diagnosis of AML to the start of intensive treatment indicate that a treatment delay has no negative prognostic impact. ht...
Episode 12. ASH 2022 Myeloma Recap
28 Dec 2022
Contributed by Lukas
1. GEM-CESAR and ASCENT Trials: Intensive Treatment Strategy in High-Risk Smoldering Multiple Myelomahttps://ash.confex.com/ash/2022/webprogram/Paper1...
Episode 11. ASH22 Recap: Lymphoma and CLL
21 Dec 2022
Contributed by Lukas
ALPINE Trial: Zanubrutinib vs Ibrutinib in Relapsed/Refractory CLL (https://www.nejm.org/doi/full/10.1056/NEJMoa2211582)Â CLL2-Give Trial: Updated res...
Episode 10. Castleman Disease
30 Nov 2022
Contributed by Lukas
Excellent overview of Castleman Disease: https://ashpublications.org/blood/article/135/16/1353/452573/Overview-of-Castleman-diseaseInternational conse...
Episode 9. CAR-T cell therapy in Lymphoma
16 Nov 2022
Contributed by Lukas
In this episode, we discussed the three CD19-directed chimeric antigen receptor (CAR T-cell) therapies that have been approved for relapsed/refractory...
Episode 8. Management of Newly Diagnosed CLL
26 Oct 2022
Contributed by Lukas
Key articles and trials discussed in the episode:1.   Excellent review in NEJM on treatment of CLL (2020): https://www.nejm.org/doi/full/10.1056...
Episode 7. Newly Diagnosed Ph-negative ALL
13 Oct 2022
Contributed by Lukas
Key papers discussed in the show: 1.   Pediatric regimen for older adolescents and young adults with ALL: CALGB 10403 https://ashpublications.or...
Episode 6. Donor Search for Allogeneic Hematopoietic Stem Cell Transplant
28 Sep 2022
Contributed by Lukas
Key papers discussed in the show:1. Landmark paper on HLA-mismatch and survival: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568127/2. HLA-DP and Ri...
Episode 5. Mentorship and Career Development
14 Sep 2022
Contributed by Lukas
In this episode, we do a thought provoking discussion with Dr. Marty Tallman on mentorship and career development in academic hematology and medical o...
Episode 4. Measurable Residual Disease in AML
24 Aug 2022
Contributed by Lukas
2021 European LeukemiaNET MRD Working Party Consensus Guidelines: https://pubmed.ncbi.nlm.nih.gov/34724563/Pre-MEASURE Study ASCO 2022: https://ascopu...
Episode 3. Management of Waldenström Macroglobulinemia
10 Aug 2022
Contributed by Lukas
https://ascopubs.org/doi/abs/10.1200/JCO.22.00495
Episode 2. CAR T-Cell Therapy in Multiple Myeloma
27 Jul 2022
Contributed by Lukas
In this episode, we discuss with Dr. Surbhi Sidana the latest advances, practical aspects of patient management, and future directions of cellular the...
Episode 1. Implications of Clonal Hematopoiesis
15 Jul 2022
Contributed by Lukas
In this episode, we bring two experts in clonal hematopoiesis, Dr. Sid Jaiswal from Stanford University and Dr. Alex Bick from Vanderbilt University t...
Introduction to BloodCancerTalks
08 Jul 2022
Contributed by Lukas
BloodCancerTalks is a new podcast focusing exclusively on hematologic malignancies. We will bring a wide range of experts to dig deep into specific to...